Projects

The purpose of SMA Europe is to provide a framework to stimulate collaboration and accelerate translational research pathways in SMA and promote patient care.

  1. Gene therapy for Spinal Muscular Atrophy by a correction of SMN2 MRNA splicing

    Principal investigator(s) :
    Dr. Rachel Nlend Nlend
    Institution :
    Universität Bern, Switzerland
    Grant :
    65,000 €
    Grant Type:
    Operating Grant
    Call number :
    2
    Start year :
    2010
    Duration :
    2 years
    Status :
    null